Medical Health & Life Science Research News

Learn details of the genome editing/genome engineering market outlook to 2021

Medical Market Research

The genome editing market is undergoing a significant transformation, with the changing landscapes of healthcare, and manufacturing industries.

- Advertising -

Inquire Before Buying @

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). 

The growth of this market is majorly influenced by the dynamics of these industries.

Factors such as rising government funding and growth in the number of genomics projects, high prevalence rate of infectious diseases and cancer among patients, technological advancements, increasing demand for synthetic genes, growing awareness about genomics, and increasing new product launches by industry players are expected to drive the genome editing market in the coming years.

- Advertising -

Rise in the production of genetically modified crops is also expected to increase the demand for genome editing.

However, the high cost of genomic equipment, shortage of trained professionals, and adverse public perception related to genetic research are restraining the growth of the market to a certain extent.

Access This Report @

Increasing use of genome editing in specialized/personalized medicine and emerging markets in developing countries like Brazil, China, and India are providing various growth opportunities for players in the genome editing market.

In 2016, North America is expected to account for the largest share of the global genome editing market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America is also projected to have the highest growth rate in the forecast period.

Factors such as the development of gene therapy in the U.S.; increasing use of GM crops; prevalence of Alzheimer’s disease, dementia, infectious diseases, and cancer in the U.S.; growing availability of research grants and funding, and genome editing standards workshops and conferences are likely to propel the market in North America.

Key Points From Table Of Content:

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Rising Government Funding and Growth in the Number of Genomics Projects High Prevalence Rate of Infectious Diseases and Cancer Among Patients Technological Advancements Increase in Demand for Synthetic Genes Rise in Production of Genetically Modified Crops Increasing Awareness About Genomics New Product Launches By Industry Players
5.2.2 Restraints High Cost of Genomic Equipment Adverse Public Perception Related to Genetic Research
5.2.3 Opportunities Use of Genome Editing in Specialized/Personalized Medicine Emerging Markets in Developing Countries
5.2.4 Challenges Off-Target Effect of CRISPR Shortage of Trained Professionals

Download sample copy @

11 Company Profiles

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

11.1 Thermo Fisher Scientific, Inc.
11.2 Merck KGaA
11.3 Horizon Discovery Group PLC
11.4 Genscript USA Inc.
11.5 Sangamo Biosciences, Inc.
11.6 Integrated DNA Technologies, Inc.
11.7 Lonza Group Ltd.
11.8 New England Biolabs, Inc.
11.9 Origene Technologies, Inc.
11.10 Transposagen Biopharmaceuticals, Inc.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany about: is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.